Cargando…
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
Seventeen years after the epidemic of SARS coronavirus, a novel coronavirus SARS-CoV-2-emerged resulting in an unprecedented pandemic. Angiotensin-converting enzyme 2 (ACE2) is an essential receptor for cell entry of SARS-CoV-2 as well as the SARS coronavirus. Despite many similarities to SARS coron...
Autores principales: | Kuba, Keiji, Yamaguchi, Tomokazu, Penninger, Josef M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727358/ https://www.ncbi.nlm.nih.gov/pubmed/35003058 http://dx.doi.org/10.3389/fimmu.2021.732690 |
Ejemplares similares
-
Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006) -
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome
por: Imai, Y., et al.
Publicado: (2007) -
Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023) -
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
por: Kuba, Keiji, et al.
Publicado: (2005) -
ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury
por: Minato, Takafumi, et al.
Publicado: (2022)